HF Acquisition Co. LLC
$46.1K 22 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Meisinger USA, LLC
Meisinger USA, LLC reported $46,011.78 across General Payments, Research, and Ownership to 358 physicians and teaching hospitals across 358 transactions.
- $46.0K Below-median payer
- All-tracks total
- 358 Above-median volume
- Transactions
- 358 Above-median reach
- Recipients
- +$120.35
- General Payments vs PY2023
Meisinger USA, LLC reported $46,011.78 across all CMS Open Payments tracks (General + Research + Ownership) to 358 physicians and teaching hospitals in Program Year 2024 - ranking #1370 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $46,011.78, averaging $128.52 per recipient.
How Meisinger USA, LLC's $46.0K all-tracks total breaks down
Meisinger USA, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
18/100
Total payments
F
10/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer meisinger-usa-llc Meisinger USA, LLC
$46.0K · #1370/1,925 · 0.0% industry · PY2024
- TOT $46.0K
- RANK #1370
- SHARE 0.0%
- TXN 358
- RCP 358
- CAT 3
- GEN $46.0K
- ΔGEN +$120.35
- TOP1 12.1%
- PY 2024
Volume peers
Nearest volume peer: HF Acquisition Co. LLC ($46.1K)
Meisinger USA, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Meisinger USA, LLC's CMS-reported General Payments increased by $120.35 (+0.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MEISINGER USA, LLCPY2023: MEISINGER USA, LLCPY2024: Meisinger USA, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $45,891.43
- PY2024
- $46,011.78
What the Data Shows for Meisinger USA, LLC
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Meisinger USA, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
347 transactions worth $41.8K make "Gift" the top general-payment category in the 3-category breakdown below, 90.9% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Meisinger USA, LLC made 3 types of general payments. "Gift" is the largest category at $41.8K, 90.9% of General Payments.
How Meisinger USA, LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Gift | $41.8K | 347 | 90.9% |
| Travel and Lodging | $3.5K | 7 | 7.6% |
| Food and Beverage | $710.84 | 4 | 1.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $14,087.06 (30.6%) of $46,011.78 in this company's General Payments records across 135 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Meisinger USA, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Daniel J Selner
$5,588.65 across 113 reported transactions
- 2
James Klim
$3,463.95 across 25 reported transactions
- 3
Jonathan Misch
$2,502.70 across 2 reported transactions
- 4
Matthew Jonas Fien
$1,448.75 across 2 reported transactions
- 5
Daniel Ray Cullum
$1,083.01 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Meisinger USA, LLC's spend rank (#1370 of 1,925, bottom 29% by spend) and concentration rank (#1,450 of 1,838, bottom 21% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Piedmont Plus Innovation : $24.7K total payments, HHI 314
- Goode Surgical Inc : $24.0K total payments, HHI 314
- Vision Quest Industries Inc. : $2.1K total payments, HHI 314
- United Orthopedics LLC : $47.9K total payments, HHI 313
- Pharmacosmos Therapeutics Inc. : $1.4M total payments, HHI 311
- Carl Zeiss Meditec Digital Innovations LLC : $167.7K total payments, HHI 311
- Meisinger USA, LLC (this company) : $46.0K total payments, HHI 310
- MedShape, Inc. : $1.2M total payments, HHI 309
- Garrison Dental Solutions : $162.0K total payments, HHI 308
- Ossio Inc : $357.9K total payments, HHI 307
- Sanara MedTech Inc. : $748.7K total payments, HHI 306
- Merz North America, Inc. : $3.5M total payments, HHI 306
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Meisinger USA, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Meisinger USA, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Meisinger USA, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
AnX Robotica Corp
$45.9K 69 recipients
Compare payment profiles
Curium US LLC
$45.9K 103 recipients
Compare payment profiles
Microtransponder, Inc.
$46.1K 662 recipients
Compare payment profiles
Hartmann USA, Inc.
$45.9K 479 recipients
Compare payment profiles
Microline Surgical Inc
$45.6K 171 recipients
Compare payment profiles
Put this to use
Meisinger USA, LLC ranks #1370 of 1,925 by all-tracks total payments, led by "Gift".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Gift" spend across every manufacturer, not just Meisinger USA, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.